Linked Data API

Show Search Form

Search Results

1109073
star this property registered interest false more like this
star this property date less than 2019-04-02more like thismore than 2019-04-02
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Hyperkalemia more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the prevalence of hyperkalaemia for patients with chronic kidney disease. more like this
unstar this property tabling member constituency Coventry South more like this
star this property tabling member printed
Mr Jim Cunningham more like this
star this property uin 239857 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove maximum value filtermore like thismore than 2019-04-08
star this property answer text <p>Hyperkalaemia usually occurs in patients with renal impairment which can be acute or chronic. In patients with chronic kidney disease (CKD), several factors increase susceptibility to hyperkalaemia including a high dietary potassium intake relative to residual renal function. When patients with CKD have other risk factors, for example treatment with drugs that interfere with the renin-angiotensin-aldosterone system, the risk of hyperkalaemia is further increased. Clinical presentation of hyperkalaemia is highly variable with some patients presenting with an acute illness whilst others may be asymptomatic.</p><p> </p><p>Although not completely preventable, the risk of developing hyperkalaemia can be reduced. Clinical practice guidelines treatment of acute hyperkalaemia in adults, a collaboration between the Renal Association and Resuscitation Council UK that is endorsed by a range of organisations, including the College of Emergency Medicine and the Faculty of Intensive Care medicine, sets out evidence-based guidance on the management of the condition. It was developed to improve the treatment of acute hyperkalaemia and to reduce the risk of complications associated with hyperkalaemia and its treatment. The main measures in primary prevention in patients with CKD are regular blood monitoring, careful drug prescribing and dietary advice. Patient information and education may reduce the risk of inadvertent hyperkalaemia. The guidance can be found at the following link:</p><p> </p><p><a href="https://renal.org/wp-content/uploads/2017/06/hyperkalaemia-guideline-1.pdf" target="_blank">https://renal.org/wp-content/uploads/2017/06/hyperkalaemia-guideline-1.pdf</a></p><p> </p><p>Information regarding the annual cost to the National Health Service of treating hyperkalaemia in Coventry South and England is not available. This answer covers England only. Funding of such services in the other United Kingdom nations is a matter for the respective devolved administrations.</p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property grouped question UIN 239865 more like this
star this property question first answered
less than 2019-04-08T15:20:04.88Zmore like thismore than 2019-04-08T15:20:04.88Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
308
unstar this property label Biography information for Mr Jim Cunningham more like this
1109260
star this property registered interest false more like this
star this property date less than 2019-04-02more like thismore than 2019-04-02
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Hyperkalemia more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what recent estimate he has made of the annual cost to the NHS of treating hyperkalaemia in (a) Coventry South constituency and (b) the UK. more like this
unstar this property tabling member constituency Coventry South more like this
star this property tabling member printed
Mr Jim Cunningham more like this
star this property uin 239865 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove maximum value filtermore like thismore than 2019-04-08
star this property answer text <p>Hyperkalaemia usually occurs in patients with renal impairment which can be acute or chronic. In patients with chronic kidney disease (CKD), several factors increase susceptibility to hyperkalaemia including a high dietary potassium intake relative to residual renal function. When patients with CKD have other risk factors, for example treatment with drugs that interfere with the renin-angiotensin-aldosterone system, the risk of hyperkalaemia is further increased. Clinical presentation of hyperkalaemia is highly variable with some patients presenting with an acute illness whilst others may be asymptomatic.</p><p> </p><p>Although not completely preventable, the risk of developing hyperkalaemia can be reduced. Clinical practice guidelines treatment of acute hyperkalaemia in adults, a collaboration between the Renal Association and Resuscitation Council UK that is endorsed by a range of organisations, including the College of Emergency Medicine and the Faculty of Intensive Care medicine, sets out evidence-based guidance on the management of the condition. It was developed to improve the treatment of acute hyperkalaemia and to reduce the risk of complications associated with hyperkalaemia and its treatment. The main measures in primary prevention in patients with CKD are regular blood monitoring, careful drug prescribing and dietary advice. Patient information and education may reduce the risk of inadvertent hyperkalaemia. The guidance can be found at the following link:</p><p> </p><p><a href="https://renal.org/wp-content/uploads/2017/06/hyperkalaemia-guideline-1.pdf" target="_blank">https://renal.org/wp-content/uploads/2017/06/hyperkalaemia-guideline-1.pdf</a></p><p> </p><p>Information regarding the annual cost to the National Health Service of treating hyperkalaemia in Coventry South and England is not available. This answer covers England only. Funding of such services in the other United Kingdom nations is a matter for the respective devolved administrations.</p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property grouped question UIN 239857 more like this
star this property question first answered
remove maximum value filtermore like thismore than 2019-04-08T15:20:04.927Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
308
unstar this property label Biography information for Mr Jim Cunningham more like this